Trials / Terminated
TerminatedNCT04527796
Influence of a Residential Rehabilitation Program on Body Composition in Patients with Cystic Fibrosis
Influence of a Residential Rehabilitation Program on Body Composition in Patients with Cystic Fibrosis (children and Adults)
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 39 (actual)
- Sponsor
- University Hospital, Ghent · Academic / Other
- Sex
- All
- Age
- 6 Years
- Healthy volunteers
- Not accepted
Summary
The aim is to evaluate the impact of a 3-week lasting residential rehabilitation program for patients with cystic fibrosis on their nutritional status measured as BMI and body composition and pulmonary function.
Detailed description
Cystic fibrosis Patients following a residential rehabilitation program consisting of dietary adaptation, physical therapy for airway drainage and supervised inhalation therapy and physical activity for at least 3 weeks are asked to participate. Weight, height, body composition and pulmonary function will be measured at start and end of the program. Dietary intake during the program is calculated based on a 2 day weighed intake diary and physical activity will be measured with the "SenseWear pro 3" armband.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Rehabilitation | During the rehabilitation program a multidisciplinary team, consisting of a pneumologist, dietician, psychologist, social worker and several physiotherapists, coach the cystic fibrosis patients. The physiotherapists help with autogenic drainage and aerosol therapy (2-3 times/day) and supervise physical activity (5, 1-hour lasting, training sessions/week: swimming 2, Fitness training 2, 1 session of choice). The dietician calculates basal and theoretical energy needs . A carbohydrate-rich snack before exercise, to improve exercise tolerance and a carbohydrate-protein-rich snack afterwards to improve recuperation is provided. |
Timeline
- Start date
- 2018-09-01
- Primary completion
- 2020-05-01
- Completion
- 2020-07-01
- First posted
- 2020-08-27
- Last updated
- 2024-09-19
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT04527796. Inclusion in this directory is not an endorsement.